Employers should keep in mind that indication-based coverage decisions (such as covering GLP-1 drugs for diabetes treatment but not for treatment of obesity or other conditions, such as addiction) can potentially raise concerns under the Americans with Disabilities Act (ADA), the ACA, HIPAAs nondiscrimination requirements, or the Mental Health Parity and Addiction Equity Act, among other laws
At the moment, GLP-1 usage poses a minimal impact to snacking sales, especially in comparison to broader macroeconomic issues like volatile inflation in parts of Europe, high costs-of-living, and compliance costs among others, Quash explains
Users with a history of multiple endocrine neoplasia syndrome or endocrine neoplasia syndrome type should discuss their options with a healthcare provider before starting treatment
Muscle recovery and athletic performance support Athletes and fitness-focused researchers represent a major segment of the penta deca peptide arginate user community
schedule consultation Ready when you are GHK-Cu (Copper Peptide) A copper peptide studied for skin and tissue support From $179/mo compounded by a licensed 503A pharmacy, dispensed only after provider review